Published Healthcare & Pharmaceuticals Paramyxovirus Therapeutics This technology is an RNA polymerase inhibitor therapeutic for use in paramyxoviruses, including parainfluenza, Nipah virus and measles. By Georgia State University
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
